CEASAR TRIA: Open Payments
NPI 1841702057 · JACKSONVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,382 in 71 payments from 19 companies in 2025. Trend: 2023 $1,656 · 2024 $1,701 · 2025 $1,382
Food & beverage: $1,382
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $261 |
| GlaxoSmithKline, LLC. | 9 | $146 |
| Novo Nordisk Inc | 6 | $123 |
| Lilly USA, LLC | 9 | $119 |
| Averitas Pharma Inc. | 3 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $70 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $68 |
| ABBVIE INC. | 3 | $67 |
| Amgen Inc. | 4 | $61 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, BREZTRI, QUTENZA, JARDIANCE, Kerendia, XIFAXAN, Wegovy.
Industry payments across NC — which companies pay providers there.
